Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Faget

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Research|July 28, 2012
Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progressionVanja Sisirak, Julien Faget, Michael Gobert, et al.
Journal for Immunotherapy of Cancer|March 26, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in miceAlexandra Fauvre, Chiara Ursino, Veronique Garambois, et al.
Science (New York, N.Y.)|December 2, 2017
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF<sup>high</sup> neutrophilsCamilla Engblom, Christina Pfirschke, Rapolas Zilionis, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Research|July 28, 2012
Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progressionVanja Sisirak, Julien Faget, Michael Gobert, et al.
Journal for Immunotherapy of Cancer|March 26, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in miceAlexandra Fauvre, Chiara Ursino, Veronique Garambois, et al.
Science (New York, N.Y.)|December 2, 2017
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF<sup>high</sup> neutrophilsCamilla Engblom, Christina Pfirschke, Rapolas Zilionis, et al.
Pageof 3